Prothena Corporation PLC
NASDAQ:PRTA

Watchlist Manager
Prothena Corporation PLC Logo
Prothena Corporation PLC
NASDAQ:PRTA
Watchlist
Price: 9.87 USD -4.36% Market Closed
Market Cap: 531.3m USD

Wall Street
Price Targets

PRTA Price Targets Summary
Prothena Corporation PLC

Wall Street analysts forecast PRTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRTA is 20.74 USD with a low forecast of 8.08 USD and a high forecast of 37.8 USD.

Lowest
Price Target
8.08 USD
18% Downside
Average
Price Target
20.74 USD
110% Upside
Highest
Price Target
37.8 USD
283% Upside
Prothena Corporation PLC Competitors:
Price Targets
MGX
Metagenomi Inc
423% Upside
CSL
CSL Ltd
40% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
45% Upside
TVTX
Travere Therapeutics Inc
23% Upside
RLYB
Rallybio Corp
32% Upside
MRNA
Moderna Inc
31% Upside
INCY
Incyte Corp
1% Upside
1801
Innovent Biologics Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Prothena Corporation PLC

For the last 13 years the compound annual growth rate for Prothena Corporation PLC's revenue is 54%. The projected CAGR for the next 3 years is -36%.

54%
Past Growth
-36%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Prothena Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Prothena Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRTA's stock price target?
Price Target
20.74 USD

According to Wall Street analysts, the average 1-year price target for PRTA is 20.74 USD with a low forecast of 8.08 USD and a high forecast of 37.8 USD.

What is Prothena Corporation PLC's Revenue forecast?
Projected CAGR
-36%

For the last 13 years the compound annual growth rate for Prothena Corporation PLC's revenue is 54%. The projected CAGR for the next 3 years is -36%.

Back to Top